Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumors Intervention: Drug: Rivoceranib Mesylate, Paclitaxel Sponsor: Asan Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials